SCYNEXIS appoints director

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
PODCASTS
SEE ALL EPISODES
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
Webinar2024 Regulatory Reporting Horizon: what to expect and how to prepare
- 12/05/2023
- Live, Online
- 03:00 pm - 04:00 pm GMT | 10:00 am- 11:00 am EST
WebinarUnderstanding, Identifying, and Assessing Supplier Diversity
- 12/06/2023
- Live, Online
- 01:00 pm - 02:00 pm EST
Webinar2024 Regulatory Reporting Horizon: what to expect and how to prepare
- 12/05/2023
- Live, Online
- 03:00 pm - 04:00 pm GMT | 10:00 am- 11:00 am EST
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

In This List

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

26 Jan, 2017 | 17:21

Author Ephraim Bie
Theme Healthcare & Pharmaceuticals

SCYNEXIS Inc. appointed Marion McCourt as a board member.

McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.